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 Cocaine inhibits high-affinity neurotransmitter uptake at the presynaptic nerve 
terminals to increase synaptic levels of dopamine, norepinephrine and serotonin1.  
This increase of synaptic dopamine may cause neurotoxicity2,3.  At least two 
different mechanisms have been proposed for the development of dopamine-related 
neurotoxicity: 1) dopamine produces a free radical that may induce cell toxicity2,3 
and 2) dopamine reduces glutamate transport at its presynaptic sites to increase 
synaptic levels of this amino acid4 and augments glutamate transmission by 
activating dopamine D1 receptors in different areas of the brain5-7.  Increase in 
glutamatergic transmission mediated by the activation on N-methyl dextro-
aspartate (NMDA) receptors has been shown to cause excitotoxicity and neuro-
degeneration8.  Others and we have reported protection against different 
psychotropic drug-induced neurotoxicity that may be achieved by prior or 
simultaneous administration of various pharmacological agents.  For example, 
repeated treatment of rats with haloperidol induced neuronal damage that is 
ameliorated by prior administration of either GM1 ganglioside9 or the endogenous 
amino acid, taurine10. Similarly, chronic gestational cocaine exposure causes 
neurotoxicity that could be prevented by co-administration of clozapine11.  To our 
knowledge, there is no information if chronic cocaine would enhance release of 
endogenous protective agents that may oppose the over activation of glutamatergic 
system.  Here we show that repeated cocaine treatment increased synaptic levels of 
the neuroprotective amino acid taurine that opposes the excessive excitatory actions 
of the glutamatergic system in the rat brain.  Thus, mammalian brain has an auto-
protective mechanism to counter excitotoxicity and taurine or its synthetic 
 derivative may be useful in the management and treatment of cocaine addiction and 
its neurotoxic effect. 
 
The effect of acute cocaine treatment on extracellular levels of glutamate and 
taurine are shown in Figure 1.  Although, there were small decreases in interstitial striatal 
levels of glutamate and taurine in the acute cocaine treated rats compared to control 
group, these differences did not reach statistical significance.  This observation regarding 
extracellular concentrations of glutamate following acute cocaine administration is in 
agreement with Miguenes et al. who reported similar results after 1 mg/kg intravenous 
cocaine treatment in the nucleus accumbens12.  Other investigators found higher 
concentrations of extracellular glutamate in the nucleus accumbens after a relatively high 
dose of 30 mg/kg intrperitoneal cocaine treatment13.  Previously, a dose of 15 mg/kg of 
systemic cocaine was shown to release somatodendritic dopamine that stimulated 
dopamine D1 receptors that in turn increased release of glutamate in the ventral tagmental 
area 14.  In contrast, it appears that lower doses of cocaine do not increase the levels of 
dopamine to a sufficient degree to activate release of glutamate in the synaptic cleft in the 
striatum (Fig. 1).  Our microdialysis experiments show that basal synaptic levels of 
striatal glutamate in rats receiving chronic cocaine decreased significantly compared to 
the control group (Fig. 2).  Interestingly, in the chronic cocaine treated group, the 
synaptic level of taurine increased by about 38% compared to the control group; but this 
difference did not reach statistical significance (Fig. 2).  The mechanism for the reduction 
of extracellular glutamate following repeated cocaine administration may be due to a 
decrease in the activity of cysteine/glutamate exchange that was reported in the nucleus 
 accumbens following long-term neuroadaptation induced by chronic cocaine exposure15.  
When our chronically cocaine treated group was challenged by an intraperitoneal 
administration of 10 mg/kg cocaine, a significant increase in extracellular concentrations 
of both glutamate and taurine were noted (Fig. 3). There are two possible mechanisms 
that may be involved in the dramatic increase of the synaptic levels of glutamate after 
chronic cocaine treatment.  First, repeated cocaine exposure may increase the number of 
dopamine D1 receptors that could enhance glutamate release14.  Such observation would 
suggest that chronic cocaine might, at least in part, cause neurotoxicity mediated by the 
release of glutamate.  Second, repeated cocaine administration may desensitize group II 
metabotropic glutamate receptors in several brain areas16, 17 and subsequently enhance 
glutamate release (Fig. 3). 
 
There are no previous reports on the release of endogenous taurine in the synaptic 
cleft after either acute or chronic cocaine treatment.  Taurine has been shown to be a 
neuroprotective agent in numerous investigations10 and several mechanisms for its 
neuroprotective effects have been proposed.  Most of the studies have suggested 
antagonism of the glutamate-induced excitotoxicity.  For example, it has been proposed 
that taurine may reduce glutamate-induced cell death by augmentation of mitotochondrial 
function and the regulation of intracellular (cytoplasmic and intramitochondrial) calcium 
homeostasis18.  Taurine was also shown to decrease D-[3H]aspartate (a non-metabolized 
analog of glutamate) release from mouse corticostriatal slices by the activation of a 
chloride channel that is insensitive to regulation by GABA and/or strychnine-sensitive 
glycine receptors19.  Moreover, acamprosate (calcium acetylhomotaurine), a synthetic 
 analog of taurine has been reported to reduce NMDA receptor activation either through 
partial agonistic activity at the spermidine site or through its action at the metabotropic 
glutamate receptors20.  Thus, multitude of mechanisms may be involved in the diminution 
of glutamate-induced excitotoxicity by taurine making it a good neuroprotective agent. 
Although, taurine and its synthetic analog acamprosate are known to be 
neuroprotective agents that are used in the treatment of drug addiction20, 23, 24, no previous 
investigation has demonstrated spontaneous release of taurine in the mammalian brain by 
substances of abuse.  We report spontaneous release of taurine after chronic, but not acute 
cocaine treatment (Figs. 1 and 3).  The amount of taurine released following acute 
administration of cocaine was not significantly different from control.  This may be 
related to the dose of the drug or the duration between drug administration and collection 
of samples for microdialysis.  Nevertheless, the results of our study suggest that the 
mammalian brain has a unique ability to counteract insult to neuronal tissue caused by 
glutamate in response to substances of abuse.  Clearly, released taurine is not sufficient to 
completely neutralize glutamate-induced excitotoxicity in all cases.  Consequently, 
excessive intake of substances of abuse would lead to the development of drug addiction 
despite mammalian brains’ effort to mitigate these adverse effects by the release of 
endogenous taurine.  Nonetheless, taurine and/or acamprosate have been found to be of 
therapeutic value in neuronal protection and in the management of cocaine, alcohol, and 
morphine addiction20-22.  Future studies may determine if prior intake of taurine or 
acamprosate would be of preventive value in mitigating neurotoxicity and addictive 
sequela to exposure to drugs of abuse. 
 
 The extracellular levels of glutamate and taurine were measured by microdialysis 
followed by high-pressure-liquid-chromatography (HPLC) in striata of male CD rats after 
acute and chronic administrations of cocaine.  Rats were anesthetized with 60 mg/kg 
intraperitoneal pentobarbital and a microdialysis guide cannula was surgically implanted 
in the striatum using these coordinates: AP, +0.7 mm; ML, +2 .7 mm; DV -6.0 mm25.  
Microdialysis probes (CMA /12; Bioanalytical Systems, West Lafayette, IN) were 
inserted into the guide cannulae and the probes were continuously perfused with artificial 
cerebrospinal fluid at a flow rate of 2 μl/min, and samples were collected every 10 min 
via a refrigerated fraction collector.  Samples were analyzed using HPLC with 
electrochemical detection.  Twenty-four CD rats were divided into four groups consisting 
of a control group, acute cocaine treated group, chronic cocaine treated group, and 
chronic cocaine group challenged with a single dose of cocaine.  Acute cocaine treated 
rats received 10 mg/kg of intraperitoneal cocaine and the control group received equal 
volume of saline 30 min before microdialysis sample collection.  Chronic cocaine treated 
group received 10 mg/kg of intraperitoneal cocaine six days each week for three weeks 
and were anesthetized for microdialysis 24 hours after the last dose of cocaine.  All 
animal procedures were in compliance with the Animal Welfare Act, the Public Health 
Service Policy on Humane Care and Use of Laboratory Animals, and the City University 
of New York (CUNY) institutional guidelines and were approved by the CCNY Animal 
Care and Use Committee.  
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 Figure Legends 
 
Fig. 1. Extracellular release of glutamate and taurine in striatum after acute 
cocaine treatment. 30-minutes before the microdialysis assay rats were injected 
intraperitoneally with 10mg/kg cocaine or an equal volume of saline (controls). There 
were no significant changes in synaptic levels of glutamate (A) or taurine (B) by the 
Two-tailed t-test: (A) t=0.004904 df=7; P>0.05; (B) t=0.9954 df=7; P>0.05. Error bars, 
s.e.m.; n=8 in A and B. 
 
Fig. 2. Extracellular release of glutamate and taurine in striatum after chronic 
cocaine treatment. Two groups of rats were injected intraperitoneally with 10mg/kg 
cocaine or equal volume of saline (controls) six-days per week for three-weeks. 
Microdialysis was initiated 24-hours after last injection of cocaine. (A) Basal level of 
glutamate in the cocaine group was significantly decreased compared to controls (Two-
tailed t-test: t=5.588 df=6; **P<0.05). (B) Basal taurine levels were increased by 37%   
compared to controls, however, this change was not statistically significant (Two-tailed t-
test: t=1.370 df=6; P>0.05).  Error bars, s.e.m.; n=7 in A and B. 
 
Fig. 3. Extracellular release of glutamate and taurine in striatum of chronic  
cocaine-treated rats measured after a cocaine “challenge”. Rats received 10 mg/kg 
coaine (i.p.) for six days per week for three weeks. 24 hours after the last chronic cocaine 
dose, rats were challenged with 10 mg/kg cocaine (i.p.) or an equal volume of saline (i.p.) 
30 minutes before microdialysis. There was a significant increase in both extracellular 
 glutamate (A) (Two-tailed t-test: t=2.456 df=6; *P<0.05) and taurine (B) (Two-tailed t-
test: t=4.469 df=6; **P<0.05).  Error bars, s.e.m.; n=7 in A and B. 
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